Kerstin Papenfuss, PhD MBA
London, England, United Kingdom
4K followers
500 connections
London, England, United Kingdom
4K followers
500 connections
About
As the Director Pharma at Deep Science Ventures, I lead the creation and development of…
Activity
-
I am proud to be serving as a US national judge for the EY Entrepreneur of the Year - US Overall competition. I am honored to participate in this…
I am proud to be serving as a US national judge for the EY Entrepreneur of the Year - US Overall competition. I am honored to participate in this…
Liked by Kerstin Papenfuss, PhD MBA
-
Two weeks ago, Female Invest announced an $11,2m Series A. Meanwhile, Camilla was giving birth.👇 👇 In fact, we signed the papers the day before…
Two weeks ago, Female Invest announced an $11,2m Series A. Meanwhile, Camilla was giving birth.👇 👇 In fact, we signed the papers the day before…
Liked by Kerstin Papenfuss, PhD MBA
-
The first entry of a new blog 'Factville' that will host ideas that move us towards a more trustable information ecosystem and shared reality. I'd…
The first entry of a new blog 'Factville' that will host ideas that move us towards a more trustable information ecosystem and shared reality. I'd…
Liked by Kerstin Papenfuss, PhD MBA
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
-
-
started PhD at German Cancer Research Centre and after move of the laboratory continued Ph.D. Thesis at Imperial College London.
-
-
-
-
-
-
Licenses & Certifications
Volunteer Experience
-
Coach
West London Eagles handball club
- 4 years 8 months
-
-
Publications
-
Immune checkpoint inhibitors: targets on the horizon
Drug Target Review
-
Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10
Br J Cancer
-
Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
Cell Death Differ
-
Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils
Leuk Lymphoma
-
TRAIL-Rezeptor-Agonisten, eine neue Klasse proapoptotischer Krebstherapeutika
Onkopipeline
-
From biochemical principles of apoptosis induction by TRAIL to application in tumour therapy
Results Probl Cell Differ
-
A comparison of procedures for purifying human basophils to near homogeneity
Inflamm Res
-
A rapid two-step procedure for the purification of human peripheral blood basophils to near homogeneity.
Clin Exp All
-
Death receptors as targets for anti-cancer therapy
J Cell Mol Med
Honors & Awards
-
Rising Star award for Collaboration
Movers and Shakers in Biotech 2018-Biobeat
-
Women in Business Award
Cass Business School
-
Scholarship for Master thesis
DAAD (German academic exchange service)
Languages
-
Deutsch
Native or bilingual proficiency
-
English
Native or bilingual proficiency
-
Französisch
Elementary proficiency
More activity by Kerstin
-
🎉 Happy 5th Birthday to Rinri! 🎉 We’re thrilled to celebrate a major milestone at Rinri Therapeutics – 5 years of pushing boundaries, pioneering…
🎉 Happy 5th Birthday to Rinri! 🎉 We’re thrilled to celebrate a major milestone at Rinri Therapeutics – 5 years of pushing boundaries, pioneering…
Liked by Kerstin Papenfuss, PhD MBA
-
Imagine a tech CEO you're considering working for or investing in. You reference check him with his former VP of Marketing who says "unfit to be a…
Imagine a tech CEO you're considering working for or investing in. You reference check him with his former VP of Marketing who says "unfit to be a…
Liked by Kerstin Papenfuss, PhD MBA
-
We have too high a high cultural tolerance for women’s suffering. It’s not regarded as important. As this article points out, Grantly Dick-Read…
We have too high a high cultural tolerance for women’s suffering. It’s not regarded as important. As this article points out, Grantly Dick-Read…
Liked by Kerstin Papenfuss, PhD MBA
-
I have understood (and in a past life, researched) the importance and impact of tuning gene expression in a non-binary way and it's future…
I have understood (and in a past life, researched) the importance and impact of tuning gene expression in a non-binary way and it's future…
Liked by Kerstin Papenfuss, PhD MBA
-
When founding Cumulus, I wanted to return to my roots in the biopharma industry and develop a portfolio of new therapeutics, regardless of modality…
When founding Cumulus, I wanted to return to my roots in the biopharma industry and develop a portfolio of new therapeutics, regardless of modality…
Liked by Kerstin Papenfuss, PhD MBA
-
Nodus Oncology is extremely grateful to Cumulus Oncology and its innovative business model which has allowed us to make rapid progress whilst…
Nodus Oncology is extremely grateful to Cumulus Oncology and its innovative business model which has allowed us to make rapid progress whilst…
Liked by Kerstin Papenfuss, PhD MBA
-
What an Olympics!! Inspiring in so many ways. I particularly loved the Women’s Rugby 7s and Team USA’s awesome performance. To bring home a medal for…
What an Olympics!! Inspiring in so many ways. I particularly loved the Women’s Rugby 7s and Team USA’s awesome performance. To bring home a medal for…
Liked by Kerstin Papenfuss, PhD MBA
-
Announcing today the spinout of HyperCIM, an in-memory computing company founded by Dr Tanya Mangoma and joined by CTO Martyn Gilbert 🎉 The team…
Announcing today the spinout of HyperCIM, an in-memory computing company founded by Dr Tanya Mangoma and joined by CTO Martyn Gilbert 🎉 The team…
Liked by Kerstin Papenfuss, PhD MBA
-
Excited to be heading to #ATE2024 joining Rosie Lindup for the ATMPs in the UK: Spotlight on the UK's Innovations and Initiatives on behalf of the…
Excited to be heading to #ATE2024 joining Rosie Lindup for the ATMPs in the UK: Spotlight on the UK's Innovations and Initiatives on behalf of the…
Liked by Kerstin Papenfuss, PhD MBA
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More